Alpha Teknova (TKNO) Non-Current Assets (2020 - 2026)
Alpha Teknova's (TKNO) quarterly Non-Current Assets came in at $67.0 million in Q1 2026, down 9.8% year-on-year from $74.3 million in Q1 2025, and down 3.03% on a QoQ basis from $69.1 million in Q4 2025.
Alpha Teknova (TKNO) Non-Current Assets (2020 - 2026) Analysis & Trends
Alpha Teknova (TKNO) has 7 years of Non-Current Assets data on file, last reported at $67.0 million in Q1 2026.
- On a quarterly basis, Non-Current Assets fell 9.8% year-over-year to $67.0 million in Q1 2026; TTM through Mar 2026 was $279.5 million, a 9.38% decrease from a year earlier, with the FY2025 full-year figure at $69.1 million, down 9.11% from the prior year.
- Non-Current Assets for Q1 2026 stood at $67.0 million, down from $69.1 million in the prior quarter.
- Over the last five years, Non-Current Assets for TKNO reached as high as $101.9 million in Q2 2022 and fell as low as $67.0 million in Q1 2026.
- Historically, Non-Current Assets has averaged $82.1 million across 5 years, with a median of $82.0 million in 2024.
- Across the five-year window, Non-Current Assets jumped 87.89% in 2022 and decreased 12.25% in 2023, its largest moves.
- Year by year, Non-Current Assets stood at $91.1 million in 2022, then retreated by 8.99% to $82.9 million in 2023, then retreated by 8.36% to $76.0 million in 2024, then slipped by 9.11% to $69.1 million in 2025, then fell by 3.03% to $67.0 million in 2026.
- Per Business Quant data, the three most recent Non-Current Assets figures were $67.0 million in Q1 2026, $69.1 million in Q4 2025, and $71.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 36.78 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 26.33 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 8.68 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 79.20 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 3.84 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 15.70 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 25.92 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2.47 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 9.64 Bn |
| 10 | Alpha Teknova | 278.75 Mn | 260.97 Mn | 3.78 Mn | 66.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 66.98 Mn |
| Dec 31, 2025 | 69.07 Mn |
| Sep 30, 2025 | 71.06 Mn |
| Jun 30, 2025 | 72.43 Mn |
| Mar 31, 2025 | 74.26 Mn |
| Dec 31, 2024 | 75.99 Mn |
| Sep 30, 2024 | 78.17 Mn |
| Jun 30, 2024 | 80.07 Mn |
| Mar 31, 2024 | 81.99 Mn |
| Dec 31, 2023 | 82.93 Mn |
| Sep 30, 2023 | 87.31 Mn |
| Jun 30, 2023 | 89.44 Mn |
| Mar 31, 2023 | 91.39 Mn |
| Dec 31, 2022 | 91.12 Mn |
| Sep 30, 2022 | 90.21 Mn |
| Jun 30, 2022 | 101.92 Mn |
| Mar 31, 2022 | 92.15 Mn |
| Dec 31, 2021 | 65.31 Mn |
| Sep 30, 2021 | 58.08 Mn |
| Jun 30, 2021 | 54.25 Mn |